LASSBio-1911
LASSBio-1911 is a potent inhibitor of HDAC6. LASSBio-1911 shows antitumor in hepatocellular carcinoma (HCC) cells with minimal on normal cells.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C17H18N4O3
- Masse moléculaire:326.35
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
|
HDAC6 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 | IC50 |
9.48 μM
Compound: 3c
|
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTS assay
Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability after 48 hrs by MTS assay
|
[PMID: 26705137] |
| HT-144 | IC50 |
21.18 μM
Compound: 3c
|
Antiproliferative activity against human HT144 cells assessed as reduction in cell viability after 48 hrs by MTS assay
Antiproliferative activity against human HT144 cells assessed as reduction in cell viability after 48 hrs by MTS assay
|
[PMID: 26705137] |
Chemical Information
-
Masse moléculaire 326.35
-
Formule C17H18N4O3
-
SMILES
O=C(N/N=C/C1=CC=C(C(NO)=O)C=C1)C2=CC=C(N(C)C)C=C2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)